Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 481

Cited In for PubMed (Select 10877736)

1.

Predictors of medication adherence among HIV-infected youth.

Hosek SG, Harper GW, Domanico R.

Psychol Health Med. 2005 May;10(2):166-179.

2.

What determines health-related quality of life among people living with HIV: an updated review of the literature.

Degroote S, Vogelaers D, Vandijck DM.

Arch Public Health. 2014 Nov 17;72(1):40. doi: 10.1186/2049-3258-72-40. eCollection 2014.

3.

Effectiveness of Psycho-Educational Intervention in HIV Patients' Treatment.

Ribeiro C, Sarmento E Castro R, Dinis-Ribeiro M, Fernandes L.

Front Psychiatry. 2015 Jan 15;5:198. doi: 10.3389/fpsyt.2014.00198. eCollection 2014.

4.

Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study.

Nyogea D, Mtenga S, Henning L, Franzeck FC, Glass TR, Letang E, Tanner M, Geubbels E.

BMC Infect Dis. 2015 Jan 31;15(1):28. [Epub ahead of print]

5.

Case Management: Steadfast Resource for Addressing Linkage to Care and Prevention with Hospitalized HIV-Infected Crack Users.

Kenya S, Chida N, Cardenas G, Pereyra M, Del Rio C, Rodriguez A, Metsch L.

J HIV AIDS Soc Serv. 2014;13(4):325-326.

6.

Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection.

Truong WR, Schafer JJ, Short WR.

P T. 2015 Jan;40(1):44-55.

7.

Determinants of Antiretroviral Therapy Adherence among Women in Southern Malawi: Healthcare Providers' Perspectives.

McKinney O, Modeste NN, Lee JW, Gleason PC, Maynard-Tucker G.

AIDS Res Treat. 2014;2014:489370. doi: 10.1155/2014/489370. Epub 2014 Dec 28.

8.

A cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocol.

Belenko S, Visher C, Copenhaver M, Hiller M, Melnick G, O'Connell D, Pearson F, Fletcher B; the HIV-STIC Workgroup of CJDATS.

Health Justice. 2013 Dec;1(1):8.

10.

A framework for community ownership of a text messaging programme to improve adherence to antiretroviral therapy and client-provider communication: a mixed methods study.

Mbuagbaw L, Bonono-Momnougui RC, Thabane L, Kouanfack C, Smieja M, Ongolo-Zogo P.

BMC Health Serv Res. 2014 Sep 26;14:441. doi: 10.1186/1472-6963-14-441.

11.

Factors that influence adherence to antiretroviral treatment in an urban population, Jakarta, Indonesia.

Weaver ER, Pane M, Wandra T, Windiyaningsih C, Herlina, Samaan G.

PLoS One. 2014 Sep 17;9(9):e107543. doi: 10.1371/journal.pone.0107543. eCollection 2014.

12.

Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.

van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET; VOICE-C Study Team.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19146. doi: 10.7448/IAS.17.3.19146. eCollection 2014.

13.

48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.

Patel DA, Snedecor SJ, Tang WY, Sudharshan L, Lim JW, Cuffe R, Pulgar S, Gilchrist KA, Camejo RR, Stephens J, Nichols G.

PLoS One. 2014 Sep 4;9(9):e105653. doi: 10.1371/journal.pone.0105653. eCollection 2014.

14.

Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis.

Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdóttir TB, Richter C, Sprangers MA, Nieuwkerk PT.

BMC Med. 2014 Aug 21;12:142. doi: 10.1186/PREACCEPT-1453408941291432.

15.

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection.

Molino Cde G, Carnevale RC, Rodrigues AT, Visacri MB, Moriel P, Mazzola PG.

Ther Clin Risk Manag. 2014 Aug 7;10:631-9. doi: 10.2147/TCRM.S61821. eCollection 2014.

16.

A Mediation Model to Explain HIV Antiretroviral Adherence Among Gay and Bisexual Men.

Halkitis PN, Palamar J.

J Gay Lesbian Soc Serv. 2008;19(1):35-55.

17.

Biomedical consequences of alcohol use disorders in the HIV-infected host.

Molina PE, Bagby GJ, Nelson S.

Curr HIV Res. 2014;12(4):265-75.

18.

Study the drug adherence and possible factor influencing drug adherence in HIV/AIDS patients in north eastern part of India.

Meena LP, Pandey SK, Rai M, Bharti A, Chakravarty J, Sundar S.

J Educ Health Promot. 2014 May 3;3:31. doi: 10.4103/2277-9531.131898. eCollection 2014.

19.

HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.

Jonas A, Sumbi V, Mwinga S, DeKlerk M, Tjituka F, Penney S, Jordan MR, Desta T, Tang AM, Hong SY.

PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.

20.

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients.

Pistone G, Pistone A, Sorbello D, Viviano E, Bongiorno MR.

Case Rep Dermatol. 2014 May 17;6(2):145-9. doi: 10.1159/000354030. eCollection 2014 May.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk